Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23300
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adenocarcinoma/blood/drug therapy,Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Carboplatin/administration & dosage/adverse effects,Carcinoma/blood/*drug therapy,Carcinoma, Squamous Cell/blood/drug therapy,Drug Administration Routes,Female,Granulocyte Colony-Stimulating Factor/administration & dosage,Humans,Male,Middle Aged,Neoplasms, Unknown Primary/blood/*drug therapy,Paclitaxel/administration & dosage/adverse effects,Tumor Markers, Biological/blood
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/23300
ISSN: 0732-183X
Link: http://www.ncbi.nlm.nih.gov/pubmed/10963638
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Briasoulis-2000-carboplatin plus paclitaxel.pdf68.79 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons